Risk factor
Limited default risk
Profitability factor
Greatly undervalued vs peers
About
JW Pharmaceutical Corporation, established in 1945 and headquartered in Seoul, South Korea, operates globally, focusing on the development, manufacturing, and distribution of a comprehensive range of pharmaceuticals and medical supplies. Its diverse product portfolio addresses numerous therapeutic areas, including cardiovascular, gastrointestinal, urinary, and metabolic health, as well as infectious diseases, women's health, renal and central nervous system disorders, anti-anemic treatments, respiratory ailments, rheumatic arthritis, oncology, anesthesia, antidotes, and advanced nutritional support.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD
Target Price
The average target price of 001060.KS is 34000 and suggests 27.8% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t